Emmaus Life Sciences, Inc.
EMMA · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $537 | $5,315 | $12,869 | $82,253 |
| - Cash | $1,389 | $2,547 | $2,021 | $2,279 |
| + Debt | $32,963 | $32,650 | $30,818 | $29,915 |
| Enterprise Value | $32,111 | $35,418 | $41,666 | $109,889 |
| Revenue | $16,653 | $29,597 | $18,390 | $20,610 |
| % Growth | -43.7% | 60.9% | -10.8% | – |
| Gross Profit | $15,452 | $28,255 | $15,802 | $17,298 |
| % Margin | 92.8% | 95.5% | 85.9% | 83.9% |
| EBITDA | -$910 | $3,623 | -$5,499 | -$12,761 |
| % Margin | -5.5% | 12.2% | -29.9% | -61.9% |
| Net Income | -$6,453 | -$3,733 | -$10,625 | -$15,946 |
| % Margin | -38.7% | -12.6% | -57.8% | -77.4% |
| EPS Diluted | -0.1 | -0.07 | -0.21 | -0.32 |
| % Growth | -42.2% | 66.5% | 34.4% | – |
| Operating Cash Flow | -$2,286 | -$1,503 | -$5,073 | -$1,254 |
| Capital Expenditures | -$12 | -$17 | -$26 | -$73 |
| Free Cash Flow | -$2,298 | -$1,520 | -$5,099 | -$1,327 |